157 related articles for article (PubMed ID: 7506559)
21. Clinical and biological activity of the interferons in hematologic malignancies.
Gutterman JU
Prog Clin Biol Res; 1989; 288():337-48. PubMed ID: 2470111
[No Abstract] [Full Text] [Related]
22. [Update on malignant hematologic diseases].
Marie JP; Delmer A
Bull Cancer; 1998 Jan; 85(1):42-4. PubMed ID: 9752345
[No Abstract] [Full Text] [Related]
23. Possible mechanism of action of interferon alpha in chronic B-cell malignancies.
Heslop HE; Brenner MK; Ganeshaguru K; Hoffbrand AV
Br J Haematol; 1991 Oct; 79 Suppl 1():14-6. PubMed ID: 1931702
[TBL] [Abstract][Full Text] [Related]
24. Interferon therapy for lymphoproliferative disorders.
Roth MS; Bunn PA; Foon KA
Cancer Treat Res; 1988; 38():231-52. PubMed ID: 2484433
[No Abstract] [Full Text] [Related]
25. Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma.
Ailawadhi S; Dholaria BR; Khurana S; Sher T; Alegria V; Paulus A; Ailawadhi M; Mehta A; Chanan-Khan A; Roy V
Br J Haematol; 2019 Apr; 185(2):347-350. PubMed ID: 29978498
[No Abstract] [Full Text] [Related]
26. [Second neoplasms in malignant hematologic disorders. Experience from 1978 to 1987].
Cristoffanini A; Zapata C; León A; Salas P
Rev Med Chil; 1990 May; 118(5):522-9. PubMed ID: 2293272
[TBL] [Abstract][Full Text] [Related]
27. [Clinical studies on interferon in cancer therapy in Japan].
Ohno R
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
[TBL] [Abstract][Full Text] [Related]
28. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
29. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1996; 16():347-75. PubMed ID: 8639390
[No Abstract] [Full Text] [Related]
30. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
31. Interferon exerts a cytotoxic effect on primary human myeloma cells.
Einhorn S; Fernberg JO; Grandér D; Lewensohn R
Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1505-10. PubMed ID: 3141198
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatment.
San-Miguel JF; Kantarjian HM
Nat Rev Clin Oncol; 2015 Feb; 12(2):71-2. PubMed ID: 25511190
[TBL] [Abstract][Full Text] [Related]
33. Therapy of chronic myelogenous leukaemia with interferons.
Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
[TBL] [Abstract][Full Text] [Related]
34. Biotherapy in clinical practice.
Figlin RA
Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
[TBL] [Abstract][Full Text] [Related]
35. The role of interferons in the treatment of hematologic malignancies.
Gutterman JU
Semin Hematol; 1988 Jul; 25(3 Suppl 3):3-8. PubMed ID: 2459780
[TBL] [Abstract][Full Text] [Related]
36. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
Baer MR; Ozer H; Foon KA
Br J Haematol; 1992 Jun; 81(2):167-9. PubMed ID: 1643013
[TBL] [Abstract][Full Text] [Related]
38. [Immunoglobulin substitution in malignant lymphoma].
Wehmeier A
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():73-6; discussion 77. PubMed ID: 8499755
[TBL] [Abstract][Full Text] [Related]
39. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
Chaidos A; Kanfer E; Apperley JF
Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
[TBL] [Abstract][Full Text] [Related]
40. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
